https://www.indianpharmapost.com/lupin-signs-exclusive-licensing-pact-with-neopharmed-for-plasil-in-philippines-and-brazil-185992025-12-19T00:00:00+05:30always0.9https://www.indianpharmapost.com/agilent-technologies-opens-india-refurbishment-center-186122025-12-19T00:00:00+05:30always0.9https://www.indianpharmapost.com/gensci-rtw-yarrow-bioscience-strike-1365-billion-global-deal-for-breakthrough-graves-disease-therapy-186112025-12-19T00:00:00+05:30always0.9https://www.indianpharmapost.com/eli-lilly-reports-positive-phase-3-results-for-oral-obesity-drug-orforglipron-186102025-12-19T00:00:00+05:30always0.9https://www.indianpharmapost.com/max-healthcare-announces-rs1000-cr-foray-into-pune-with-450-bed-super-speciality-hospital-186092025-12-19T00:00:00+05:30always0.9https://www.indianpharmapost.com/jhs-svendgaard-to-invest-rs-25-crore-on-building-new-manufacturing-unit-186082025-12-19T00:00:00+05:30always0.9https://www.indianpharmapost.com/novo-nordisk-files-fda-application-for-once-weekly-obesity-drug-cagrisema-186072025-12-19T00:00:00+05:30always0.9https://www.indianpharmapost.com/ystral-expands-in-india-with-new-bangalore-facility-boosting-team-local-production-186062025-12-19T00:00:00+05:30always0.9https://www.indianpharmapost.com/sabic-launches-first-fluorine-free-polycarbonate-resin-to-boost-medical-device-safety-186052025-12-19T00:00:00+05:30always0.9https://www.indianpharmapost.com/ambros-therapeutics-launches-with-125-million-to-advance-breakthrough-therapy-for-rare-pain-disorder-186042025-12-19T00:00:00+05:30always0.9https://www.indianpharmapost.com/roche-unveils-major-upgrade-to-cobas-68008800-systems-boosting-lab-efficiency-186032025-12-19T00:00:00+05:30always0.9https://www.indianpharmapost.com/takeda-joins-baselaunch-to-boost-early-stage-biotech-ventures-in-europe-186022025-12-19T00:00:00+05:30always0.9https://www.indianpharmapost.com/immunomes-varegacestat-shows-dramatic-results-in-phase-3-desmoid-tumor-trial-186012025-12-19T00:00:00+05:30always0.9https://www.indianpharmapost.com/gileads-new-hiv-therapy-shows-promising-phase-3-results-186002025-12-19T00:00:00+05:30always0.9https://www.indianpharmapost.com/thyrocare-appoints-dr-ramesh-kinha-as-coo-186132025-12-19T00:00:00+05:30always0.9